# TOPAMAX
> **NDA020505** · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 1996-12-24
## Drug
- **FDA Application Number:** NDA020505
- **Application type:** New Drug Application
- **Brand name:** TOPAMAX
- **Generic name:** TOPIRAMATE
- **Active ingredients:** TOPIRAMATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** JANSSEN PHARMS
- **Manufacturer:** Janssen Pharmaceuticals, Inc.
- **First approval:** 1996-12-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020505)
---
*AI Analytics · CC0 1.0*